Point of Care Nano-Technology, Inc. (PCNT)

USD 0.01

(0.0%)

Total Liabilities Summary of Point of Care Nano-Technology, Inc.

Point of Care Nano-Technology, Inc.'s latest annual total liabilities in 2023 was 266.41 Thousand USD , down -33.71% from previous year.
Point of Care Nano-Technology, Inc.'s latest quarterly total liabilities in 2023 FY was 266.41 Thousand USD , up 24.88% from previous quarter.
Point of Care Nano-Technology, Inc. reported annual total liabilities of 213.33 Thousand USD in 2022, up 954.03% from previous year.
Point of Care Nano-Technology, Inc. reported annual total liabilities of 20.24 Thousand USD in 2021, up 58.87% from previous year.
Point of Care Nano-Technology, Inc. reported quarterly total liabilities of 266.41 Thousand USD for 2023 Q4, down -40.66% from previous quarter.
Point of Care Nano-Technology, Inc. reported quarterly total liabilities of 238.29 Thousand USD for 2023 Q3, up 1.02% from previous quarter.

Annual Total Liabilities Chart of Point of Care Nano-Technology, Inc. (2023 - 2010)

Historical Annual Total Liabilities of Point of Care Nano-Technology, Inc. (2023 - 2010)

Year	Total Liabilities	Total Liabilities Growth
2023	266.41 Thousand USD	-33.71%
2022	213.33 Thousand USD	954.03%
2021	20.24 Thousand USD	58.87%
2020	12.74 Thousand USD	0.0%
2015	320.38 Thousand USD	-8.22%
2014	349.07 Thousand USD	28.42%
2013	271.83 Thousand USD	69.54%
2012	160.33 Thousand USD	329.99%
2011	37.28 Thousand USD	148.59%
2010	15 Thousand USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q1	238.29 Thousand USD	1.02%
2023 Q4	266.41 Thousand USD	-40.66%
2023 Q3	238.29 Thousand USD	1.02%
2023 Q2	235.89 Thousand USD	-1.01%
2023 FY	266.41 Thousand USD	24.88%
2022 Q2	76.28 Thousand USD	22.07%
2022 Q4	235.89 Thousand USD	29.45%
2022 Q3	182.22 Thousand USD	138.86%
2022 FY	213.33 Thousand USD	954.03%
2022 Q1	62.49 Thousand USD	208.76%
2021 FY	20.24 Thousand USD	58.87%
2021 Q4	20.24 Thousand USD	0.0%
2020 FY	12.74 Thousand USD	0.0%
2015 Q4	320.38 Thousand USD	11.45%
2015 Q3	287.45 Thousand USD	-1.42%
2015 Q2	291.6 Thousand USD	11.38%
2015 Q1	261.81 Thousand USD	-25.0%
2015 FY	320.38 Thousand USD	-8.22%
2014 FY	349.07 Thousand USD	28.42%
2014 Q3	421.58 Thousand USD	8.35%
2014 Q2	389.09 Thousand USD	29.0%
2014 Q1	301.62 Thousand USD	10.96%
2014 Q4	349.07 Thousand USD	-17.2%
2013 Q4	271.83 Thousand USD	9.23%
2013 FY	271.83 Thousand USD	69.54%
2013 Q3	248.85 Thousand USD	9.98%
2013 Q2	226.27 Thousand USD	13.54%
2013 Q1	199.28 Thousand USD	24.29%
2012 Q1	78.68 Thousand USD	111.01%
2012 Q2	112.62 Thousand USD	43.14%
2012 Q3	135.51 Thousand USD	20.32%
2012 Q4	160.33 Thousand USD	18.32%
2012 FY	160.33 Thousand USD	329.99%
2011 Q4	37.28 Thousand USD	1710.15%
2011 FY	37.28 Thousand USD	148.59%
2011 Q3	2060.00 USD	0.0%
2010 FY	15 Thousand USD	0.0%

Peer Total Liabilities Comparison of Point of Care Nano-Technology, Inc.

Name	Total Liabilities	Total Liabilities Difference
America Great Health	4.82 Million USD	94.478%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	7.94 Million USD	96.647%
Innovation1 Biotech Inc.	3.5 Million USD	92.401%
Vicapsys Life Sciences, Inc.	1.96 Million USD	86.465%